556771179	556771179	CD	B-NP	O
|	|	NNP	I-NP	O
MD	MD	NNP	I-NP	O
|	|	VBD	B-VP	O
71663369	71663369	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8451264	8451264	CD	B-NP	O
|	|	CC	I-NP	O
6/4/2005	6/4/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
NSTEMI/PCI	NSTEMI/PCI	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/27/2005	7/27/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/13/2005	7/13/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
MOMAN	MOMAN	NN	B-NP	O
,	,	,	O	O
CARMELO	CARMELO	NN	B-NP	O
089-62-23-0	089-62-23-0	CD	I-NP	O
Mi	Mi	NNP	I-NP	O
Yonkers	Yonkers	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
3/22/05	3/22/05	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BERNITSKY	BERNITSKY	NNP	B-NP	O
,	,	,	O	O
TRACY	TRACY	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	NNP	I-NP	O
ASA	ASA	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
5/30	5/30	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/28/05	5/28/05	CD	B-NP	O
by	by	IN	B-PP	O
DUCHATELLIER	DUCHATELLIER	NN	B-NP	O
,	,	,	O	O
TED	TED	NNP	B-NP	O
DEREK	DEREK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
5/30	5/30	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PLAVIX	PLAVIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PROTONIX	PROTONIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
GLIPIZIDE	GLIPIZIDE	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
METFORMIN	METFORMIN	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
6	6	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
AVANDIA	AVANDIA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ROSIGLITAZONE	ROSIGLITAZONE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4	4	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Avoid	Avoid	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
or	or	CC	O	O
strenuous	strenuous	JJ	B-NP	O
activity	activity	NN	I-NP	O
until	until	IN	B-SBAR	O
you	you	PRP	B-NP	O
see	see	VBP	B-VP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Follow-up	Follow-up	NN	B-NP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Roszales	Roszales	NNP	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Follow-up	Follow-up	NN	B-NP	O
with	with	IN	B-PP	O
cardiologist	cardiologist	NN	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Crankshaw	Crankshaw	NNP	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
3-4	3-4	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
NSTEMI/PCI	NSTEMI/PCI	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NSTEMI/PCI	NSTEMI/PCI	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
cabg/imi	cabg/imi	NN	I-NP	O
CHF	CHF	NN	I-NP	O
30-35	30-35	CD	B-NP	O
%	%	NN	I-NP	O
EF	EF	NN	I-NP	O
,	,	,	O	O
10/19	10/19	CD	B-NP	O
h/o	h/o	NN	I-NP	O
suicide	suicide	NN	I-NP	O
attempt	attempt	NN	I-NP	O
NIDDM	NIDDM	NN	I-NP	O
non-healing	non-healing	JJ	I-NP	O
ulcers	ulcer	NNS	I-NP	O
r/o	r/o	VBP	B-VP	O
ostomyelitis	ostomyelitis	NN	B-NP	O
h/o	h/o	NN	I-NP	O
DVT	DVT	NN	I-NP	O
L	L	NN	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PCI	PCI	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
angina	angina	NN	B-NP	O
72	72	CD	I-NP	O
M	M	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
CAD	CAD	NN	I-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
x4	x4	NN	I-NP	I-protein
who	who	WP	B-NP	O
presenteds	presented	VBZ	B-VP	O
with	with	IN	B-PP	O
NSTEMI	NSTEMI	NN	B-NP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
s/p	s/p	VBP	B-VP	O
PCI	PCI	NN	B-NP	B-protein
with	with	IN	B-PP	O
stenting	stente	VBG	B-VP	O
to	to	TO	B-PP	O
SVG	SVG	NNP	B-NP	O
.	.	.	O	O

HPI	HPI	LS	B-LST	B-cell_type
:	:	:	O	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
,	,	,	O	O
Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
DOE	DOE	NNP	B-NP	O
with	with	IN	B-PP	O
dry	dry	JJ	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
rapid	rapid	JJ	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
anorexia	anorexia	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
f/c	f/c	NN	I-NP	O
,	,	,	O	O
exertional	exertional	JJ	B-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
exercise	exercise	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	O
.	.	.	O	O

Went	Went	JJ	B-ADJP	O
to	to	TO	B-PP	O
PCP	PCP	NN	B-NP	B-protein
,	,	,	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
ST	ST	JJ	B-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
lateral	lateral	JJ	B-NP	O
leads	lead	NNS	I-NP	O
accompanied	accompany	VBN	B-VP	O
by	by	IN	B-PP	O
mid	mid	JJ	B-NP	O
abd	abd	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

Sent	Sent	JJ	B-ADJP	O
to	to	TO	B-PP	O
Alegrace	Alegrace	NNP	B-NP	O
Ha	Ha	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
ED	ED	NNP	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
CK	CK	NN	B-NP	O
808	808	CD	I-NP	O
and	and	CC	O	O
sent	send	VBN	B-VP	O
to	to	TO	B-PP	O
cath	cath	NN	B-NP	B-protein
lab	lab	NN	I-NP	I-protein
.	.	.	O	O

Cath	Cath	NNP	B-NP	O
showed	show	VBD	B-VP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
diagonal	diagonal	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
om	om	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
PDA	PDA	NN	I-NP	O
grafts	graft	VBZ	B-VP	O
occlusions	occlusion	NNS	B-NP	O
.	.	.	O	O

Transferred	Transfer	VBN	B-VP	O
to	to	TO	B-PP	O
MH	MH	NN	B-NP	O
for	for	IN	B-PP	O
PCI	PCI	NN	B-NP	B-protein
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
Diabetes	Diabetes	NN	B-NP	O
with	with	IN	B-PP	O
retinopathy	retinopathy	NN	B-NP	O
,	,	,	O	O
PVD	PVD	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
x	x	SYM	B-NP	I-protein
4	4	CD	I-NP	I-protein
-LRB-	-LRB-	SYM	I-NP	O
1997	1997	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
w	w	NN	I-NP	O
3	3	CD	B-NP	O
SVGs	SVG	NNS	I-NP	O
to	to	TO	B-PP	O
Diag	Diag	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
,	,	,	O	O
OM	OM	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
PDA	PDA	NN	B-NP	B-protein
and	and	CC	I-NP	O
LIMA	LIMA	NN	I-NP	B-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
Hyperlipidema	Hyperlipidema	NNP	B-NP	O
,	,	,	O	O
UGIB	UGIB	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
h.	h.	NN	I-NP	O
pylori	pylori	NN	I-NP	O
positive	positive	JJ	I-NP	O
1998	1998	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
Anemia	Anemia	NN	B-NP	O
,	,	,	O	O
DVT	DVT	NN	B-NP	O
,	,	,	O	O
Depression	Depression	NN	B-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
suicide	suicide	NN	I-NP	O
attempt	attempt	NN	I-NP	O
,	,	,	O	O
RBKA	RBKA	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
5/17	5/17	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Discharge	Discharge	NNP	I-NP	O
PE	PE	NNP	I-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	B-protein
98.9	98.9	CD	I-NP	I-protein
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
68	68	CD	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	O
90-120/50	90-120/50	CD	I-NP	O
,	,	,	O	O
rr	rr	NN	B-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
NAD	NAD	NN	I-NP	I-protein
,	,	,	O	O
PERRL	PERRL	NN	B-NP	B-protein
.	.	.	O	O

JVP	JVP	NN	B-NP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
SEM	SEM	NN	B-NP	O
at	at	IN	B-PP	O
LUSB	LUSB	NNP	B-NP	B-protein
.	.	.	O	O

Abd	Abd	NN	B-NP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
DP	DP	NN	I-NP	O
pulse	pulse	NN	I-NP	O
on	on	IN	B-PP	O
left	left	JJ	B-ADJP	O
,	,	,	O	O
s/p	s/p	VB	B-VP	O
right	right	JJ	B-NP	O
BKA	BKA	NN	I-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
cath	cath	NN	I-NP	O
site	site	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
bruit	bruit	NN	I-NP	O
or	or	CC	I-NP	O
hematoma	hematoma	NN	I-NP	O
,	,	,	O	O
Aox3	Aox3	NN	B-NP	B-protein
and	and	CC	O	O
nonfocal	nonfocal	JJ	B-ADJP	O
.	.	.	O	O

STUDIES	STUDIES	NNS	B-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
CXR	CXR	NN	I-NP	B-protein
-LRB-	-LRB-	SYM	O	O
4/9	4/9	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
pending	pende	VBG	B-PP	O
-	-	HYPH	B-NP	O
EKG	EKG	NN	I-NP	B-protein
-LRB-	-LRB-	SYM	I-NP	O
4/9	4/9	CD	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
:	:	:	O	O
ST	ST	JJ	B-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
,	,	,	O	O
V4-V6	V4-V6	NN	B-NP	O
,	,	,	O	O
flipped	flipped	JJ	B-NP	O
T	T	NN	I-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
v5-v6	v5-v6	CD	B-NP	O
-	-	HYPH	I-NP	O
Adenosine	Adenosine	NNP	I-NP	O
Mibi	Mibi	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/15/2004	7/15/2004	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
EF	EF	NN	B-NP	O
21	21	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
severely	severely	RB	B-NP	O
dilated	dilated	JJ	I-NP	O
LV	LV	NN	I-NP	O
,	,	,	O	O
akinesis	akinesis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
apical	apical	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
wall	wall	NN	I-NP	O
,	,	,	O	O
apex	apex	NN	B-NP	O
and	and	CC	O	O
entire	entire	JJ	B-NP	O
inferior	inferior	JJ	I-NP	O
wall	wall	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
RV	RV	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Cath	Cath	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
4/9	4/9	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-ADJP	O
:	:	:	O	O
R	R	NN	B-NP	O
dominant	dominant	JJ	B-ADJP	O
.	.	.	O	O

90	90	CD	B-NP	O
%	%	NN	I-NP	O
LM	LM	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
Circ	Circ	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
Marg2	Marg2	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
RCA	RCA	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
SVG	SVG	NN	I-NP	O
--	--	:	O	O
>	>	SYM	O	O
PDA	PDA	NN	B-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
SVG	SVG	NN	I-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
RAMUS	RAMUS	NNS	I-NP	B-protein
stented	stente	VBD	B-VP	O
to	to	TO	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
Proxis	Proxis	NN	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
of	of	IN	I-NP	O
4	4	CD	I-NP	O
grafts	graft	NNS	I-NP	O
patent	patent	NN	I-NP	O
.	.	.	O	O

Rotor	Rotor	NN	B-NP	O
atherectomy	atherectomy	NN	I-NP	O
of	of	IN	B-PP	O
distal	distal	JJ	B-NP	O
native	native	JJ	I-NP	O
LM	LM	NN	I-NP	O
to	to	TO	B-PP	O
prox	prox	NN	B-NP	O
circ	circ	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
:	:	:	O	O
10/11	10/11	CD	B-NP	O
30-35	30-35	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
HK/AK	HK/AK	NN	B-NP	B-protein
inf/infseptal/posterolateral	inf/infseptal/posterolateral	JJ	I-NP	O
walls	wall	NNS	I-NP	O
-LRB-	-LRB-	TO	B-PP	O
RCA	RCA	NN	B-NP	O
distribution	distribution	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
minimally	minimally	RB	B-VP	O
changed	change	VBN	I-VP	O
from	from	IN	B-PP	O
1997	1997	CD	B-NP	O
Hospital	Hospital	NN	I-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
:	:	:	O	O
s/p	s/p	NN	B-NP	O
PCI	PCI	NN	I-NP	O
with	with	IN	B-PP	O
stent	stent	NN	B-NP	O
to	to	TO	B-PP	O
SVG	SVG	NN	B-NP	O
and	and	CC	I-NP	O
rotor	rotor	NN	I-NP	O
atherectomy	atherectomy	NN	I-NP	O
to	to	TO	B-PP	O
LM	LM	NN	B-NP	B-protein
`	`	``	I-NP	I-protein
circ	circ	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
standard	standard	JJ	B-NP	O
post-op	post-op	JJ	I-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
toprol	toprol	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
lisinopril	lisinopril	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
meds	med	NNS	I-NP	O
were	be	VBD	B-VP	O
hemodynamically	hemodynamically	RB	I-VP	O
tolerated	tolerate	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
discharge	discharge	NN	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

PUMP	PUMP	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
echo	echo	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
depressed	depressed	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
~	~	NN	B-NP	O
30-35	30-35	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

RHYTHM	RHYTHM	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
with	with	IN	B-PP	O
occassional	occassional	JJ	B-NP	O
4-6	4-6	CD	I-NP	O
beat	beat	NN	I-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
NSVT	NSVT	NN	B-NP	B-protein
.	.	.	O	O

EP	EP	NN	B-NP	B-protein
saw	see	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
reassess	reassess	VB	I-VP	O
for	for	IN	B-PP	O
AICD	AICD	NN	B-NP	O
insertion	insertion	NN	I-NP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
distory	distory	NN	I-NP	O
of	of	IN	B-PP	O
anemia	anemia	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
DC	DC	NN	I-NP	B-cell_type
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
31.6	31.6	CD	B-NP	O
-RRB-	-RRB-	HYPH	B-PRT	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	B-protein
but	but	CC	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

DIABETES	DIABETES	NNS	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
oral	oral	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
U	U	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
sugar	sugar	NN	I-NP	O
was	be	VBD	B-VP	O
well-controlled	well-controlled	JJ	B-ADJP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
requried	requrie	VBD	B-VP	O
~	~	RBR	B-NP	O
7-8	7-8	CD	I-NP	O
U	U	NN	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
on	on	IN	B-PP	O
RISS	RISS	NN	B-NP	B-protein
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
original	original	JJ	I-NP	O
diabetic	diabetic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
told	tell	VBN	I-VP	O
to	to	TO	I-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
discuss	discuss	VB	B-VP	O
his	his	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
regimen	regimen	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
.	.	.	O	O

Admission	Admission	NNP	B-NP	O
Weight	Weight	NNP	I-NP	O
7/1	7/1	CD	I-NP	O
kgs	kg	NNS	I-NP	O
,	,	,	O	O
Discharge	Discharge	NN	B-NP	O
weight	weight	NN	I-NP	O
1/1	1/1	CD	B-NP	O
kgs	kg	NNS	I-NP	O
ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Please	Please	NNP	I-NP	O
take	take	VB	B-VP	O
all	all	DT	B-NP	O
your	your	PRP$	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
outlined	outline	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
discharge	discharge	NN	I-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
especially	especially	RB	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Please	Please	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Viniard	Viniard	NNP	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Please	Please	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Toxey	Toxey	NNP	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
3-4	3-4	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Please	Please	NN	I-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
perform	perform	VB	I-VP	O
any	any	DT	B-NP	O
exercise	exercise	NN	I-NP	O
or	or	CC	O	O
strenuous	strenuous	JJ	B-NP	O
activity	activity	NN	I-NP	O
until	until	IN	B-SBAR	O
you	you	PRP	B-NP	O
see	see	VBP	B-VP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Sauseda	Sauseda	NNP	I-NP	O
No	No	NNP	I-NP	O
dictated	dictate	VBD	B-VP	O
summary	summary	JJ	B-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
WYSS	WYSS	NNP	B-NP	O
,	,	,	O	O
EDWARDO	EDWARDO	NNP	B-NP	O
B.	B.	NNP	I-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WH02	WH02	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3/22/05	3/22/05	CD	I-NP	O
@	@	SYM	B-NP	O
04	04	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

